Karyopharm (KPTI) Sell-Off Overdone, Leerink Partners Says

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. CVS
10. SPY

Go back to Karyopharm (KPTI) Sell-Off Overdone, Leerink Partners Says

Karyopharm Therapeutics (KPTI) Moves to Session Lows

August 10, 2015 2:00 PM EDT

Karyopharm Therapeutics (NASDAQ: KPTI) has moved to session lows following Q2 results reported before markets opened Monday. Shares are down over 39 percent and reached a 52-week low at $13.36 today. Volume at over 1.7 million shares compares with average daily volume of about 335,000 shares.

KPTI... More

Karyopharm Therapeutics (KPTI) Misses Q2 EPS by 15c

August 10, 2015 7:41 AM EDT

Karyopharm Therapeutics (NASDAQ: KPTI) reported Q2 EPS of ($0.92), $0.15 worse than the analyst estimate of ($0.77). Revenue for the quarter came in at $150 thousand versus the consensus estimate of $90 thousand.

Financial Outlook

Based on current operating plans, Karyopharm expects that its existing... More